ANDA 86962, held by Strides Pharma Intl. Hydralazine Hydrochloride.
As of Nov 16, 2026, ANDA 86962 (Hydralazine Hydrochloride), held by Strides Pharma Intl, was first approved by FDA on Feb 27, 1980, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 27, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydralazine Hydrochloride50MG ยท tablet;oral | Hydralazine Hydrochloride | Discontinued |
| Dec 11, 2001 | Supplement 30Labeling | Approved | None posted |
| Nov 4, 1988 | Supplement 29Labeling | Approved | None posted |
| Jul 14, 1988 | Supplement 28Labeling | Approved | None posted |
| May 7, 1986 | Supplement 23Manufacturing | Approved | None posted |
| Jul 28, 1983 | Supplement 17Manufacturing | Approved | None posted |
| Jul 28, 1983 | Supplement 18Manufacturing | Approved | None posted |
| Jul 28, 1983 | Supplement 19Manufacturing | Approved | None posted |
| Jul 28, 1983 | Supplement 21Manufacturing | Approved | None posted |
| Mar 16, 1982 | Supplement 15Manufacturing | Approved | None posted |
| Feb 27, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters